$CBAY CymaBay Therapeutics, Inc. Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in CymaBay Therapeutics, Inc..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in CymaBay Therapeutics, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in CymaBay Therapeutics, Inc. for free.

CIK Number: 0001042074
IRS Number: 943103561
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: CBAY
Company Address: 7575 GATEWAY BOULEVARD SUITE 110 NEWARK 94560
Phone number: 510-293-8800
Former name: METABOLEX INC, date of change: 1997-07-10

CymaBay Therapeutics, Inc. is a clinical stage biopharmaceutical company, focused on developing and providing access to therapies for patients with liver and other chronic diseases with high unmet medical need. Its products include MBX-8025 and Arhalofenate, MBX-8025 aims to treat lipid and liver diseases while Arhalofenate intends to reduce gout flares and serum uric acid. The company was founded on October 5, 1988 and is headquartered in Newark, CA.

Market Capitalization: $52.52M
Prev close: $2.05
Average Daily Volume: 363,679
Days Low: $2.01
Year Low: $0.82
Year High: $3.04

CymaBay Therapeutics, Inc. Insiders Active In Last 3 Months

NamePositionTotal SharesCurrent Value ($)Last 3 MonthsBuy / SellLast Transaction
Dorling JanetChief Commercial Officer00Aug 05 20192 months ago
Shah SujalChief Executive Officer120,000246,000shares bought: 100,000 / shares sold: 0 STRONG BUYOct 15 2019yesterday

View all CymaBay Therapeutics, Inc. insiders.

CymaBay Therapeutics, Inc. Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Oct 15 2019CBAYCymaBay Therapeuti ...Shah SujalChief Executive Off ...BuyP4.305,00021,500120,000115 K to 120 K (+4.35 %)
Sep 24 2019CBAYCymaBay Therapeuti ...Shah SujalChief Executive Off ...BuyP5.553,10017,205115,000111.9 K to 115 K (+2.77 %)
Sep 24 2019CBAYCymaBay Therapeuti ...Shah SujalChief Executive Off ...BuyP5.501,90010,450111,900110 K to 111.9 K (+1.73 %)
Aug 05 2019CBAYCymaBay Therapeuti ...Dorling JanetChief Commercial Of ...Option ExerciseA5.64341,0001,923,240341,000
Feb 08 2019CBAYCymaBay Therapeuti ...GOLDFISCHER CARLDirectorOption ExerciseM5.509,34051,3700
Feb 08 2019CBAYCymaBay Therapeuti ...GOLDFISCHER CARLDirectorOption ExerciseM5.002,33511,6750
Feb 08 2019CBAYCymaBay Therapeuti ...GOLDFISCHER CARLDirectorSellS9.0211,675105,328011.7 K to 0 (-100.00 %)
Feb 08 2019CBAYCymaBay Therapeuti ...GOLDFISCHER CARLDirectorBuyM5.509,34051,37011,6752.3 K to 11.7 K (+400.00 %)
Feb 08 2019CBAYCymaBay Therapeuti ...GOLDFISCHER CARLDirectorBuyM5.002,33511,6752,3350 to 2.3 K
Jan 31 2019CBAYCymaBay Therapeuti ...Menold DanielVice President, Fin ...Option ExerciseA8.4369,156582,98569,156
Jan 31 2019CBAYCymaBay Therapeuti ...Dickinson KlaraChief Regulatory Of ...Option ExerciseA8.43138,3121,165,970138,312
Jan 31 2019CBAYCymaBay Therapeuti ...Quinlan Paul TGeneral CounselOption ExerciseA8.4386,445728,73186,445
Jan 31 2019CBAYCymaBay Therapeuti ...Boudes Pol FChief Medical Offic ...Option ExerciseA8.43138,3121,165,970138,312
Jan 31 2019CBAYCymaBay Therapeuti ...McWherter CharlesChief Science Offic ...Option ExerciseA8.43172,8911,457,471172,891
Jan 31 2019CBAYCymaBay Therapeuti ...Shah SujalChief Executive Off ...Option ExerciseA8.43328,4922,769,188328,492

View all CymaBay Therapeutics, Inc. insider transactions.